InvestorsHub Logo
Followers 145
Posts 27561
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Thursday, 03/12/2020 9:37:41 AM

Thursday, March 12, 2020 9:37:41 AM

Post# of 3987
Protalix Bio +9% on capital raise

Mar. 12, 2020 9:33 AM ET|About: Protalix BioTherapeutics, ... (PLX)|By: Mamta Mayani, SA News Editor
Protalix BioTherapeutics (PLX) Q4 results:

Revenues: $54.7M (+59.9%).

Net loss: ($18.3M) (+30.9%); loss/share: ($1.23) (+31.7%).

Also, the company has agreed to issue and sell ~17.6M unregistered common shares at $2.485, for gross proceeds of ~$43.7M in a private placement.

Net proceeds from the financing will be used to advance clinical programs for the treatment of Fabry disease and for general corporate purposes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News